Cosmos Health Inc.
COSMNasdaqIndustrials · Wholesale-Drugs, Proprietaries & Druggists' Sundries · NV · SEC filings ↗ · Compare ⊕
View price & chart on Yahoo Finance ↗Financials
SEC XBRL · annual| FY25 | FY24 | FY23 | FY22 | FY21 | FY20 | |
|---|---|---|---|---|---|---|
| Revenue | $65.3M | $54.4M | $53.4M | $50.3M | $56.2M | $55.4M |
| Operating income | −$16.7M | −$15.5M | −$21.8M | −$7.5M | −$4.5M | $2.7M |
| Net income | −$19.1M | −$16.2M | −$18.5M | −$13.8M | −$8.0M | $820,786 |
| Total assets | $65.5M | $54.3M | $66.0M | $68.0M | $49.4M | $43.8M |
| Total liabilities | $47.1M | $29.8M | $30.0M | $28.4M | $45.0M | $48.0M |
| Equity | $18.4M | $24.5M | $36.0M | $39.3M | $4.4M | −$4.2M |
| EPS (diluted) | $-0.63 | $-1.17 | $-2.15 | $-33.16 | $-23.74 | $0.06 |
| Shares out. | 27.3M | 17.6M | 10.6M | 17.5M | 16.1M | 13.3M |
Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.
Key ratios
from filings · FY2025- Operating margin
- −25.6%
- Net margin
- −29.3%
- Return on equity
- −103.9%
- Return on assets
- −29.2%
- Return on capital (ROCE)
- −61.4%
- Liabilities / assets
- 71.9%
- Debt / equity
- 2.55×
- Book value / share
- $0.68
- Revenue growth (YoY)
- 19.9%
- Net income growth (YoY)
- —
Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.
Financial health
forensic scores · FY2025- Altman Z″ (distress)
- -7.92distress
- Accruals / assets
- −16.3%clean
- Beneish M-Score
- -3.29normal
- Piotroski F-Score
- 4/9mixed
Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.
Quality score
EDS ScoreOur own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast. What these scores mean →
Signs
● 2 severe● 4 warning● 2 good- Altman Z″ in the distress zone
- Filed a late-filing notice (Form NT) — missed an SEC deadline
- Operating losses (negative operating margin)
- Reported a net loss
- High leverage (liabilities > 70% of assets)
- Negative operating cash flow
- Revenue is growing year-over-year
- Clean earnings (low accruals)
Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.
Risk flags
late SEC filings- NT 10-Qmissed a reporting deadline ↗May 15, 2026
- NT 10-Kmissed a reporting deadline ↗Apr 1, 2026
- NT 10-Qmissed a reporting deadline ↗Aug 15, 2025
- NT 10-Kmissed a reporting deadline ↗Mar 31, 2025
- NT 10-Qmissed a reporting deadline ↗Aug 15, 2024
- NT 10-Qmissed a reporting deadline ↗May 16, 2024
A Form NT means the company notified the SEC it would file a periodic report late — often an accounting, audit or liquidity warning sign. Also search SEC enforcement actions for this company.
5%+ owners
SEC Schedule 13D / 13G · last 3 yrs- Bovopoulos AndreasPassive (13G)Apr 24, 2026
- Armistice Capital, LlcPassive (13G)Aug 14, 2025
- Siokas GrigoriosActivist (13D)May 27, 2025
Holders who disclosed a 5%+ stake. 13D signals intent to influence or control; 13G is a passive holding. Latest filing per holder — open it for the exact stake.
Short interest
FINRA · bi-monthly| Settlement | Shares short | Days to cover | Δ vs prior |
|---|---|---|---|
| May 15, 2026 | 976,746 | 1.1 | +57.0% |
| Apr 30, 2026 | 622,196 | 1.0 | +22.0% |
| Apr 15, 2026 | 510,079 | 1.0 | +219.2% |
| Mar 31, 2026 | 159,819 | 1.0 | +6.9% |
| Mar 13, 2026 | 149,459 | 1.0 | -55.5% |
Shares sold short as reported to FINRA. Days-to-cover = short shares ÷ average daily volume — higher means more potential squeeze pressure.
Material events
SEC Form 8-K · most recent- Results of operationsMay 22, 2026
- Results of operationsApr 16, 2026
- Delisting / listing-standard noticeDec 18, 2025
- Results of operations · Regulation FD disclosureNov 17, 2025
- Regulation FD disclosure · Other material eventOct 17, 2025
- Director / officer changeOct 6, 2025
- Director / officer change · Amended charter or bylaws · Shareholder voteOct 1, 2025
- Regulation FD disclosureSep 29, 2025
Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.
Recent SEC filings
All filings ↗- PRE 14AMay 22, 2026
- 8-KFORM 8-KMay 22, 2026
- 10-QFORM 10-QMay 20, 2026
- NT 10-QMay 15, 2026
- RWMay 11, 2026
- SCHEDULE 13G/AApr 24, 2026
- S-3/AApr 24, 2026
- 8-KFORM 8-KApr 16, 2026
- 10-KFORM 10-KApr 15, 2026
- NT 10-KApr 1, 2026
- SCHEDULE 13G/AMar 10, 2026
- 4FORM 4Feb 13, 2026
- 4FORM 4Feb 12, 2026
- 4FORM 4Jan 26, 2026
- 4FORM 4Jan 21, 2026
Event-driven situations (1)
Spot an error in this record? Report it. Every correction is verified against the source filing before we change anything.